AlphAIalphai — Financial news for AI agents
MinichartMAY 164 min read$HHS

Harte Hanks, Inc. Q1 2026 Financial Report: Revenue, Segment Performance, and Accounting Policies Overview

Harte Hanks, Inc. (NASDAQ: HHS) has released its Q1 2026 financial results, reporting a narrowed net loss of $392,000 compared to Q1 2025, though EPS showed a deeper loss. The Revenue Solutions segment generated $7.92 million, highlighting its importance as the primary revenue driver, while the company maintains a healthy liquidity position with $8.98 million in cash. Investors are advised to monitor the company's path to profitability and segment performance due to ongoing losses and slight equity erosion.

Original reporting
Minichart
Published May 16, 2026, 5:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 16, 2026, 5:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Harte Hanks, Inc. Q1 2026 Financial Report: Revenue, Segment Performance, and Accounting Policies Overview — source image
Source · Minichart
Decision brief

The 30-second read

$HHSNeutralLow
01

Why it matters

The recent financial results suggest a period of transition; investors should watch for signs of operational improvements or continued losses.

02

Market read

While the company's financials are mixed, the limited relevance to broader markets suggests a focus on sector-specific dynamics.

03

What to watch

Potential strategic initiatives or market share gains not yet reflected in the current financials could alter the outlook.

Timing: short-term (next 1-2 weeks)

Background

Harte Hanks, Inc. is a marketing services company focusing on customer engagement and data-driven marketing solutions.

Company-level read

Ticker impact

$HHSNeutralMedium confidence
Context

Primary focus due to recent financial results.

Expected impact

Potential sideways movement with slight downward bias in the short term.

Evidence & confidence

The financial report indicates a modest improvement in net loss but a deeper EPS loss, suggesting cautious investor sentiment. The company's revenue and cash position are stable, but ongoing losses and equity erosion warrant caution.

Market effects

Sector

The company's performance may influence the broader marketing and advertising services sector, especially among peers with similar revenue models.

Regional

Limited regional impact given the company's US-based operations and niche market focus.

Global

Minimal, as Harte Hanks operates primarily within the US and serves a specific industry segment.

Counterpoint

What could challenge this read

The company may be undervalued if turnaround efforts succeed, leading to potential upside in the medium term.

Key entities

  • Company
    Harte Hanks, Inc.

    A provider of marketing and customer engagement solutions.

Read at source← All news

Related articles

AUG 14
$HHSHighAI 9/10

Harte Hanks To Be Acquired By Star Equity For $38.4 Mln

Harte Hanks (HHS) and Star Equity Holdings (STRR) announced a merger in which Star Equity will acquire Harte Hanks for $5 per share, totaling about $38.4 million, about a 100% premium to Harte Hanks’ unaffected price, according to the companies. A 30-day go-shop runs until Sept. 13, with closing expected in 60 to 90 days. HHS was up 3.91% to $2.920 premarket.

rttnews.com3 min
AUG 14
$HHSHighAI 10/10

Harte Hanks, Inc.: Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Harte Hanks (NASDAQ:HHS) and Star Equity Holdings (NASDAQ:STRR) entered a definitive merger agreement under which Star Equity will acquire all Harte Hanks shares for $5.00 per share, about $38.4 million total equity value. Consideration is 50% cash and 50% Star Equity 10% preferred stock. Closing is expected in 60 to 90 days.

finanznachrichten.de4 min
AUG 14
$HHSHighAI 9/10

Harte Hanks stock rises on $5 per share acquisition deal

Harte Hanks Inc (NASDAQ:HHS) shares rose 2.1% premarket after Star Equity Holdings Inc (NASDAQ:STRR) agreed to acquire HHS for $5.00 per share. The deal implies about $38.4M aggregate equity value, a 100% premium. HHS shareholders may take $5 cash or 0.50 shares of STRRP preferred. Board approved; expected close in 60-90 days.

investing.com3 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min
SEP 8
$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

theyeshivaworld.com2 min
SEP 8
$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

yahoo.com2 min